Stay updated on ARCHES-2 Study: ARO-ANG3 Clinical Trial
Sign up to get notified when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.

Latest updates to the ARCHES-2 Study: ARO-ANG3 Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov navigation, announcing updates and a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The study record itself still displays a 403 error.SummaryDifference1%

- Check18 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe study details page now returns a 403 Forbidden response, blocking access to the usual NCT04832971 content and leaving a generic error page instead.SummaryDifference0.5%

- Check46 days agoChange DetectedAccess to the study record now shows a 403 Forbidden page with a Home button, replacing the previous study details. This indicates a site access restriction rather than a change to the study information.SummaryDifference19%

Stay in the know with updates to ARCHES-2 Study: ARO-ANG3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.